Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
Lauri S. Tock, MHA
Advertisement
Articles by Lauri S. Tock, MHA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
3
Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL
4
Gene Therapy Reduces LV Mass in Friedreich Ataxia Cardiomyopathy
5